These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31560113)

  • 21. Nephropathic cystinosis in children: An overlooked disease.
    Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Topical Cysteamine in Corneal Cystinosis: A Systematic Review and Meta-Analysis.
    Kaur S; Sarma P; Kaur H; Prajapat M; Shekhar N; Bhattacharyya J; Kaur H; Kumar S; Medhi B; Ram J; Das D; Avti P; Prakash A; Singh R; Bhattacharyya A
    Am J Ophthalmol; 2021 Mar; 223():275-285. PubMed ID: 32888903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis.
    McKenzie B; Kay G; Matthews KH; Knott R; Cairns D
    Int J Pharm; 2016 Dec; 515(1-2):575-582. PubMed ID: 27771488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence.
    Castro-Balado A; Cuartero-Martínez A; Pena-Verdeal H; Hermelo-Vidal G; Schmidt A; Montero B; Hernández-Blanco M; Zarra-Ferro I; González-Barcia M; Mondelo-García C; Giráldez MJ; Yebra-Pimentel E; Otero-Espinar FJ; Fernández-Ferreiro A
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis.
    Kaiser-Kupfer MI; Fujikawa L; Kuwabara T; Jain S; Gahl WA
    N Engl J Med; 1987 Mar; 316(13):775-9. PubMed ID: 3821824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops
    Sergio P; Giancarlo I; Matteo F; Maria SC; Gianni P; Parrilla R; Valente P; Luca B
    Eur J Ophthalmol; 2022 Nov; 32(6):3358-3362. PubMed ID: 35125035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sustained release cysteamine microsphere/thermoresponsive gel eyedrop for corneal cystinosis improves drug stability.
    Jimenez J; Washington MA; Resnick JL; Nischal KK; Fedorchak MV
    Drug Deliv Transl Res; 2021 Oct; 11(5):2224-2238. PubMed ID: 33543397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.
    Castro-Balado A; Bandín-Vilar E; Cuartero-Martínez A; García-Quintanilla L; Hermelo-Vidal G; García-Otero X; Rodríguez-Martínez L; Mateos J; Hernández-Blanco M; Aguiar P; Zarra-Ferro I; González-Barcia M; Mondelo-García C; Otero-Espinar FJ; Fernández-Ferreiro A
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis.
    Bradbury JA; Danjoux JP; Voller J; Spencer M; Brocklebank T
    Eye (Lond); 1991; 5 ( Pt 6)():755-60. PubMed ID: 1800180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NIH conference. Cystinosis: progress in a prototypic disease.
    Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T
    Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro drug release and in vivo safety of vitamin E and cysteamine loaded contact lenses.
    Dixon P; Fentzke RC; Bhattacharya A; Konar A; Hazra S; Chauhan A
    Int J Pharm; 2018 Jun; 544(2):380-391. PubMed ID: 29217475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis].
    Fernández-Ferreiro A; Luaces-Rodríguez A; Díaz-Tomé V; Gil-Martínez M; Rodríguez Ares MT; Touriño Peralba R; Blanco-Méndez J; González-Barcia M; Otero-Espinar FJ; Lamas MJ
    Farm Hosp; 2017 Nov; 41(6):678-687. PubMed ID: 29112493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review.
    Makuloluwa AK; Shams F
    Clin Ophthalmol; 2018; 12():227-236. PubMed ID: 29416314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectral domain optical coherence tomography-based retinochoroidal cystine crystal score: a window into infantile nephropathic cystinosis.
    Keidel L; Hohenfellner K; Schworm B; Priglinger S; Luft N; Priglinger C
    Br J Ophthalmol; 2023 Feb; 107(2):234-241. PubMed ID: 34531199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride.
    Liang H; Labbé A; Baudouin C; Plisson C; Giordano V
    Br J Ophthalmol; 2021 May; 105(5):608-613. PubMed ID: 32593979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up and treatment of adults with cystinosis in the Netherlands.
    Geelen JM; Monnens LA; Levtchenko EN
    Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
    Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
    Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.
    Tsilou ET; Rubin BI; Reed G; Caruso RC; Iwata F; Balog J; Gahl WA; Kaiser-Kupfer MI
    Ophthalmology; 2006 Jun; 113(6):1002-9. PubMed ID: 16603246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of topical cysteamine drops on reducing crystal formation within the cornea of patients affected by nephropathic cystinosis.
    MacDonald IM; Noel LP; Mintsioulis G; Clarke WN
    J Pediatr Ophthalmol Strabismus; 1990; 27(5):272-4. PubMed ID: 2246744
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.